• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Psychosom Med . Emotional Distress, Targeted Rejection, and Antibody Production Following Influenza Vaccination in Adolescence

tetano

Editor, Senior Moderator
Psychosom Med


. 2022 Jan 28.
doi: 10.1097/PSY.0000000000001054. Online ahead of print.
Emotional Distress, Targeted Rejection, and Antibody Production Following Influenza Vaccination in Adolescence


Kelsey L Corallo[SUP] 1 [/SUP], Sarah M Lyle, Michael A Carlock, Ted M Ross, Katherine B Ehrlich



Affiliations

Abstract

Objective: The purpose of this study was to explore how both ongoing emotional distress and the experience of a targeted rejection over the past six months are associated with adolescents' antibody response to influenza virus vaccination. We predicted that experiencing a targeted rejection would amplify the hypothesized negative association between emotional distress and antibody response following vaccination.
Methods: Adolescent participants (N = 148) completed two study visits (M days between visits = 27.4, SD = 1.8). At the first visit, they provided blood samples, were administered the seasonal (2018-2019) quadrivalent influenza vaccine (FluzoneTM, Sanofi Pasteur), completed questionnaires, and participated in a semi-structured interview. At the second visit, they provided another blood sample. Hemagglutination-inhibition (HAI) assays were conducted to determine pre- and post-vaccination antibody titers. Targeted rejection experiences were coded from adolescents' interviews.
Results: The Emotional Distress × Targeted Rejection interaction predicted antibody response to the two A strains and the composite of all vaccine strains (bs = -.451 to -.843, ps < .05), but not the two B strains. Results suggested that among adolescents who experienced a targeted rejection over the past six months, emotional distress was negatively associated with vaccine response (however, this finding did not reach statistical significance). Conversely, among adolescents who did not experience a targeted rejection, emotional distress was positively associated with vaccine response (b = 0.173, p = 0.032).
Conclusion: The current study highlights the importance of evaluating both acute life events and ongoing distress as they relate to adaptive immune functioning in adolescence.
 
Back
Top Bottom